Hong Kong Pharma Stock News

Why Longfor Group Holdings Stock Is Back in Focus After Its March Sales Update Longfor Group Holdings (SEHK:960) has put fresh numbers on the table, reporting unaudited contracted sales and revenue for March and the past 3 months of 2026. This gives you new data to assess its property exposure. See our latest analysis for Longfor Group Holdings. The March sales update has arrived after a weak run for the stock, with a 7 day share price return of 8.07% contrasting with a 30 day share price...

Why China Tower’s latest earnings matter for investors China Tower (SEHK:788) reported first quarter 2026 sales of CN¥25,146 million and net income of CN¥3,985 million, compared with CN¥24,771 million and CN¥3,024 million a year earlier, drawing fresh attention to the stock. See our latest analysis for China Tower. Following the earnings release and the proposed share issuance mandate, the share price at HK$11.03 has a 1 year total shareholder return of 5.13% and a 3 year total shareholder...

Huishang Bank (SEHK:3698) has gained regulatory approval to amend its Articles of Association, abolishing its Board of Supervisors and shifting those supervisory powers to the Audit Committee under the Board, a meaningful governance change for shareholders. See our latest analysis for Huishang Bank. The governance shift arrives alongside very strong momentum, with Huishang Bank’s 30 day share price return of 17.02% and 90 day share price return of 51.38%. The 1 year total shareholder return...

Lenovo Group (SEHK:992) is back in focus after Konecta announced a wide ranging alliance that positions Lenovo as a core technology partner for a new AI led digital workplace and employee experience model. See our latest analysis for Lenovo Group. Against this backdrop, Lenovo’s short term momentum has been strong, with a 30 day share price return of 22.29% at a latest share price of HK$11.3, while the 1 year total shareholder return of 45.29% points to sustained interest building over a...

Why BYD’s latest moves are back on investors’ radar BYD (SEHK:1211) is drawing fresh attention as it applies to join the European Automobile Manufacturers' Association, prepares for mass production in Hungary, and rolls out an AI powered in car assistant with Cerence. See our latest analysis for BYD. Those European expansion steps and the new Cerence powered assistant come as BYD’s share price has gained momentum recently, with a 12.3% 3 month share price return. However, its 1 year total...

If you are wondering whether COSCO SHIPPING Holdings at HK$14.70 still offers value, you are not alone. The recent share performance has put its pricing firmly in the spotlight for many investors. The stock has seen a 4.8% decline over the last 7 days and a 7.8% decline over the last 30 days. Year to date it is up 5.8%, the 1 year return sits at 48.1%, the 3 year return is 143.6%, and the 5 year return is 217.2%. These moves sit against a backdrop of ongoing attention on global shipping...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

TCL Electronics Holdings recently announced the RM9L RGB‑Mini LED TV series, its most advanced RGB–Mini LED lineup to date, featuring up to 6,000 peak nits, more than 3,800 local dimming zones, Dolby Vision 2 Max support, and Bang & Olufsen audio across 85", 98", and 115" models priced at US$7,999.99, US$9,999.99, and US$29,999.99 respectively. This move signals TCL’s push deeper into the premium large‑screen TV segment by pairing its RGB–Mini LED and CSOT panel technology with high‑end...

China XLX Fertiliser (SEHK:1866) issued new earnings guidance for the three months to 31 March 2026, flagging double digit year on year growth in revenue, net profit and earnings per share. See our latest analysis for China XLX Fertiliser. The new guidance lands after a strong run in the shares, with the latest price at HK$11.88, a 90 day share price return of 18.21% and a 1 year total shareholder return of over 3x. This suggests momentum has been building around the earnings outlook. If this...

Ascletis Pharma (SEHK:1672) announced the selection of its ASC30_39 fixed dose combination obesity therapy candidate for clinical development. The company plans to file an IND with the U.S. FDA in the third quarter of 2026. See our latest analysis for Ascletis Pharma. That obesity announcement comes after a strong run in the shares, with the latest price at HK$18.48, a 30 day share price return of 25.03% and a 1 year total shareholder return of 274.09%. This suggests momentum has been...

Seazen Group (SEHK:1030) has released its contracted sales update for March and the first quarter of 2026, giving investors fresh insight into how much buyer demand the developer is currently capturing. See our latest analysis for Seazen Group. At a share price of HK$2.19, Seazen Group has seen a 1-day share price return of 1.39% and a 7-day share price return of 4.78%. Its 1-year total shareholder return of 5.29% contrasts with a much weaker 5-year total shareholder return of negative...

In April 2026, ANTA Sports Products Limited reported that first-quarter 2026 retail sales grew at high-single digit rates for ANTA, low-teens for FILA, and 40%–45% for its other brands compared with the same period in 2025. This broad-based sales acceleration across both core and emerging brands highlights how ANTA’s multi-brand approach is gaining traction with consumers. Next, we’ll explore how this strong first-quarter, including 40%–45% growth in other brands, may influence ANTA’s...

RemeGen announced that China’s NMPA has approved a new indication for its antibody-drug conjugate Disitamab Vedotin, in combination with Toripalimab, to treat HER2-expressing locally advanced or metastatic urothelial carcinoma, marking the drug’s fifth approved use in China. This approval is underpinned by a large Phase III trial showing the combo outperformed standard platinum-based chemotherapy across the full spectrum of HER2 expression, reinforcing the clinical relevance of pairing...

In April 2026, Konecta announced a global alliance with Lenovo to co-develop AI-led Digital Workplace Solutions and Employee Experience offerings, progressively rolling Lenovo services out to more than 100,000 employees worldwide. This evolution from a conventional vendor arrangement to a unified, AI-enabled digital workplace model positions Lenovo as a central technology partner in rethinking how enterprises structure IT outsourcing and employee support. Next, we’ll examine how Lenovo’s...

How NetEase’s Recent Performance Sets the Stage NetEase (SEHK:9999) has drawn fresh attention after a mixed stretch in the share price, with a small move higher over the past week set against weaker returns over the month and past 3 months. For investors, that contrast raises questions about how the current HK$182.30 share price lines up with NetEase’s business profile across online games, music, education tools and other internet services in China and overseas. See our latest analysis for...

The market seemed underwhelmed by last week's earnings announcement from CNQC International Holdings Limited ( HKG:1240...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Hanking Gold International Limited's ( HKG:3788 ) recent weak earnings report didn't cause a big stock movement...

China Saftower International Holding Group Limited ( HKG:8623 ) insiders who bought shares over the past year were...

The subdued stock price reaction suggests that Health and Happiness (H&H) International Holdings Limited's ( HKG:1112...

Shanghai Realway Capital Assets Management Co., Ltd.'s (HKG:1835) stock price has dropped 27% in the previous week, but...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Investors were disappointed by Central China Management Company Limited's ( HKG:9982 ) latest earnings release. We did...

Unsurprisingly, ASMPT Limited's ( HKG:522 ) stock price was strong on the back of its healthy earnings report. However...